Edition:
United States

TSO3 Inc (TOS.TO)

TOS.TO on Toronto Stock Exchange

0.80CAD
18 May 2018
Change (% chg)

$0.03 (+3.90%)
Prev Close
$0.77
Open
$0.78
Day's High
$0.85
Day's Low
$0.77
Volume
198,198
Avg. Vol
255,139
52-wk High
$3.30
52-wk Low
$0.56

Chart for

About

TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment. The Company's... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $72.06
Shares Outstanding(Mil.): 92.89
Dividend: --
Yield (%): --

Financials

  TOS.TO Industry Sector
P/E (TTM): -- 39.22 32.53
EPS (TTM): -0.14 -- --
ROI: -54.22 14.34 12.63
ROE: -79.45 17.22 14.50

BRIEF-TSO3 Inc- Appointed Linda Rosenstock As Chairperson Of Board

* TSO3 ANNOUNCES THE VOTE RESULTS FROM ITS ANNUAL MEETING OF THE SHAREHOLDERS AND THE APPOINTMENT NEW CHAIRPERSON

May 10 2018

BRIEF-TSO3 Reports Qtrly Net Loss Was $0.05 Per Share

* Q1 REVENUES EQUALED $0.3 MILLION, AS COMPARED TO $4.2 MILLION IN Q1 OF 2017

May 08 2018

BRIEF-TSO3 Reports Qtrly ‍Loss Per Share​ of $0.02

* QTRLY ‍REVENUES INCREASED TO $5.8 MILLION, AS COMPARED TO $5.1 MILLION IN Q3 OF 2017 AND $3.7 MILLION IN Q4 OF 2016​

Mar 20 2018

BRIEF-TSO3 Says Provided Final Additional Information Response To U.S. Regulators

* TSO3 - PROVIDED FINAL ADDITIONAL INFORMATION RESPONSE TO U.S. REGULATORS IN SUPPORT OF EXTENDING CLAIMS OF CO'S STERIZONEVP4 STERILIZER

Mar 19 2018

BRIEF-TSO3 Provides An Operational Update

* TSO3 INC - COMPANY ENDED 2017 WITH $14.8 MILLION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AND NO DEBT Source text for Eikon: Further company coverage:

Jan 25 2018

BRIEF-TSO3 Provides Duodenoscope Regulatory Filing Update

* TSO3 - DIALOGUE WITH U.S. REGULATORS IN CONNECTION WITH REQUEST FOR AI REGARDING CO'S SUBMISSION TO EXTEND CLAIMS OF STERIZONE VP4 STERILIZER

Dec 19 2017

Earnings vs. Estimates